Kathleen Patricia Richton

CA·SEDI

enGene Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 24 Jul 2026 for enGene Therapeutics Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Kathleen Patricia Richton: trading record in brief

All filings by Kathleen Patricia Richton on record concern enGene Therapeutics Inc. Altogether 2 filings, all relating to 16 July 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 24 July 2026: a transaction, in enGene Therapeutics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.